Verrica Pharmaceuticals Inc.
VRCA • NASDAQ
Verrica Pharmaceuticals Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jayson Rieger, with a market cap of $75.2M.
CEOJayson Rieger
Next Earnings
Upcoming earnings announcement for Verrica Pharmaceuticals Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.59
Revenue Estimate
$4.6M
Earnings History
Past 12 earnings reports for Verrica Pharmaceuticals Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 11, 2026 | Q4 2025 | -$0.51Est: -$0.56 | +8.9% | $5.1MEst: $4.4M | +15.9% |  10-K |
| Nov 14, 2025 | Q3 2025 | $0.13Est: -$0.97 | +113.4% | $14.3MEst: $12.7M | +13.4% | 10-Q |
| Aug 12, 2025 | Q2 2025 | $0.25Est: -$0.78 | +132.1% | $12.7MEst: $4.6M | +178.6% | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.08Est: -$0.14 | +42.9% | $3.4MEst: $2.5M | +35.9% | 10-Q |
| Mar 11, 2025 | Q4 2024 | -$0.18Est: -$0.24 | +25.0% | $344.0KEst: $1.3M | -73.5% | 10-K |
| Nov 4, 2024 | Q3 2024 | -$0.43Est: -$0.37 | -16.2% | -$1.8MEst: $4.6M | -138.5% | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.31Est: -$0.42 | +26.2% | $5.2MEst: $4.4M | +18.5% | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.38Est: -$0.40 | +5.0% | $3.8MEst: $2.8M | +37.6% | 10-Q |
| Feb 29, 2024 | Q4 2023 | -$0.53Est: -$0.53 | 0.0% | $2.0MEst: $910.0K | +118.5% | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.32Est: -$0.36 | +11.1% | $2.9MEst: $510.0K | +472.0% | — |
| Aug 8, 2023 | Q2 2023 | -$0.21Est: -$0.21 | 0.0% | $182.0KEst: $70.0K | +160.0% | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.13Est: -$0.19 | +31.6% | $37.0KEst: $430.0K | -91.4% | — |